Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:ACBFFOTCMKTS:CLIGFOTCMKTS:OXBDFOTCMKTS:SEIGY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeACBFFAurora Cannabis$4.85+2.1%$4.44$2.20▼$12.53$4.66BN/A4.22 million shs757,577 shsCLIGFClinigen Group$8.02$8.02$8.02▼$11.56$1.07B0.498,620 shsN/AOXBDFOxford Biomedica$3.93$3.70$3.15▼$5.68$416.07M1.0913,400 shsN/ASEIGYSemperit Aktiengesellschaft$3.85$3.93$2.61▼$4.34$316.83M0.371,203 shsN/A10 Stocks Set to Soar in Spring 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceACBFFAurora Cannabis0.00%+0.21%+25.00%-26.63%-24.92%CLIGFClinigen Group0.00%0.00%0.00%0.00%0.00%OXBDFOxford Biomedica0.00%0.00%+24.65%-21.47%+1.73%SEIGYSemperit Aktiengesellschaft0.00%0.00%-3.75%+40.00%+22.61%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationACBFFAurora CannabisN/AN/AN/AN/AN/AN/AN/AN/ACLIGFClinigen GroupN/AN/AN/AN/AN/AN/AN/AN/AOXBDFOxford BiomedicaN/AN/AN/AN/AN/AN/AN/AN/ASEIGYSemperit AktiengesellschaftN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceACBFFAurora Cannabis 0.00N/AN/AN/ACLIGFClinigen Group 0.00N/AN/AN/AOXBDFOxford Biomedica 0.00N/AN/AN/ASEIGYSemperit Aktiengesellschaft 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookACBFFAurora CannabisN/AN/AN/AN/AN/AN/ACLIGFClinigen Group$704.71M1.51$1.43 per share5.60$4.52 per share1.77OXBDFOxford Biomedica$111.34M3.74N/AN/A$1.01 per share3.89SEIGYSemperit Aktiengesellschaft$780.36M0.41$1.20 per share3.21N/A∞Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateACBFFAurora CannabisN/A$0.1240.42∞N/AN/AN/AN/AN/ACLIGFClinigen Group$40.78MN/A0.00∞N/AN/AN/AN/AN/AOXBDFOxford Biomedica-$195.90MN/A0.00N/AN/AN/AN/AN/AN/ASEIGYSemperit Aktiengesellschaft-$18.19MN/A0.00∞N/A2.51%3.80%1.73%5/14/2025 (Estimated)Compare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthACBFFAurora CannabisN/AN/AN/AN/AN/ACLIGFClinigen GroupN/AN/AN/AN/AN/AOXBDFOxford BiomedicaN/AN/AN/AN/AN/ASEIGYSemperit Aktiengesellschaft$0.071.82%N/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioACBFFAurora CannabisN/AN/AN/ACLIGFClinigen GroupN/AN/AN/AOXBDFOxford Biomedica1.482.352.07SEIGYSemperit Aktiengesellschaft0.471.881.27Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipACBFFAurora CannabisN/ACLIGFClinigen GroupN/AOXBDFOxford BiomedicaN/ASEIGYSemperit AktiengesellschaftN/AInsider OwnershipCompanyInsider OwnershipACBFFAurora CannabisN/ACLIGFClinigen GroupN/AOXBDFOxford BiomedicaN/ASEIGYSemperit AktiengesellschaftN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableACBFFAurora CannabisN/A960.96 millionN/ANot OptionableCLIGFClinigen Group1,069133.03 millionN/ANot OptionableOXBDFOxford Biomedica891105.96 millionN/ANot OptionableSEIGYSemperit Aktiengesellschaft4,60082.29 millionN/ANot OptionableACBFF, OXBDF, SEIGY, and CLIGF HeadlinesRecent News About These CompaniesSemperit AG Holding ADR (SEIGY)May 11 at 7:41 AM | nasdaq.comSemperit Aktiengesellschaft (OTCMKTS:SEIGY) Trading Up 8.5% - Here's What HappenedMay 2, 2025 | marketbeat.comCRISPIDEA PRIVATE LIMITED Upgrades Siemens Aktiengesellschaft - Depositary Receipt () (SIEGY)April 9, 2025 | msn.comEQS-News: Semperit: Executive Board mandate of CFO Helmut Sorger extended until 2028February 25, 2025 | markets.businessinsider.comKepler Capital Sticks to Its Hold Rating for Semperit Holding AG (SEIGF)January 10, 2025 | markets.businessinsider.comKepler Capital Remains a Hold on Semperit Holding AG (SEIGF)November 9, 2024 | markets.businessinsider.comEQS-AFR: Semperit AG Holding: Release of a Financial reportNovember 7, 2024 | markets.businessinsider.comEQS-News: Semperit increases profitability in Q1–3 and confirms outlook for 2024November 7, 2024 | markets.businessinsider.comSemperit AG Holding (SMPV)October 24, 2024 | investing.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeACBFF, OXBDF, SEIGY, and CLIGF Company DescriptionsAurora Cannabis OTCMKTS:ACBFF$4.85 +0.10 (+2.11%) As of 05/9/2025Aurora Cannabis Inc is a Canada-based company engaged in the production and distribution of medical cannabis. The Company is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, home cultivation, wholesale and retail distribution. The Company's purpose-built facilities, which integrate technologies across all processes, are defined by automation and customization. The Company has a funded capacity of more than 500,000 kilograms per year, as well as sales and operations in more than 10 countries worldwide.Clinigen Group OTCMKTS:CLIGF$8.02 0.00 (0.00%) As of 03/24/2023Clinigen Group plc operates as a pharmaceutical and services company in the United Kingdom, rest of Europe, the United States, South Africa, Australia, and internationally. It operates through Services and Products divisions. The company provides a set of niche and high value services to pharma and biotech clients prior to product launch. It also provides access to critical medicines around the world for patients with unmet needs. In addition, the company provides a portfolio of specialist medicines to service the needs of healthcare professionals and their patients in both licensed and unlicensed markets. Further, it offers Nortriptyline Colonis for the treatment of depressive disorder; Metformin Colonis for the treatment of type 2 diabetes mellitus; Magnesium Chewable Tablets, an oral magnesium supplements for the treatment of patients with chronic magnesium loss; Iloprost, a concentrate for solution for infusion; Glycopyrronium Bromide, an oral solution for the treatment of severe sialorrhoea; Acetylcysteine, an oral solution for the treatment of respiratory disorders associated with thick, viscous, and mucus hypersecretion; Cardioxane that protects the heart against the cardiotoxic effects of anthracyclines; Ethyol, which protect against the harmful effects of chemotherapy medications and radiation treatment; Proleukin for the treatment of kidney cancer; Imukin that is used in chronic granulomatous disease; Totect, a dexrazoxane product; Foscavir, an anti-virals that work by stopping viruses from multiplying in number; and Savene, which is indicated in adults for the treatment of anthracycline extravasation. The company was incorporated in 2008 and is headquartered in Burton-on-Trent, the United Kingdom.Oxford Biomedica OTCMKTS:OXBDF$3.93 0.00 (0.00%) As of 05/9/2025Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems. The company operates in two segments, Platform and Product. The Platform segment engages in bioprocessing and process development activities for third parties. The Product segment is involved in the research and development of new gene therapeutic product candidates. The company collaborates with pharmaceutical and biotechnology companies providing viral vector development and manufacturing services in lentivirus, adeno-associated virus, and adenoviral vectors. The company was formerly known as Pinco 838 Limited and changed its name to Oxford Biomedica plc in October 1996. Oxford Biomedica plc was incorporated in 1996 and is headquartered in Oxford, the United Kingdom.Semperit Aktiengesellschaft OTCMKTS:SEIGY$3.85 0.00 (0.00%) As of 05/9/2025Semperit Aktiengesellschaft Holding develops, produces, and sells rubber products for the medical and industrial sectors worldwide. It operates through two segments: Semperit Industrial Applications and Semperit Engineered Applications. The company provides hydraulic and industrial hoses; conveyor belts; escalator handrails; profiles for windows, doors and facades, cable car rings, and ski foils; and products for railroad superstructures and toolmaking; and precision liquid silicone parts. It offers handrails; engineered solutions; and provides elastomer and sealing profiles for windows, doors, and facades; and elastomer and wear-resistant protective sheeting. It serves agriculture, bulk transportation systems, construction, manufacturing, health care, mining and port facilities, shipping, packing, household, renewable energy and power generation, process, steel, and automotive industries. Semperit Aktiengesellschaft Holding was founded in 1824 and is headquartered in Vienna, Austria. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Palantir’s Latest Deal Could Put a Freeze on Its Stock Price A 90-Day Tariff Pause Sends Alibaba Flying—BlackRock Was Ready BP Buyout Buzz Puts Spotlight on Transocean’s Comeback Potential Here's Why Call Option Traders Love Dutch Bros Stock Can Shopify Stock Make a Comeback After an Earnings Sell-Off? MarketBeat Week in Review – 05/05 - 05/09 Taiwan Semiconductor Has a New Reason to Rally on Chip Curbs 5 Reasons the Rebound in Microchip Technology Stock Is Real Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
